Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare hyper-IgE syndrome characterized by atopic dermatitis (eczema), chronic mucocutaneous candidiasis, and elevated IgE levels due to ZNF341 deficiency. High plasma levels of IgG and low natural killer (NK) cell numbers are observed. Other major clinical features involve recurrent skin infections with skin abscesses and connective tissue abnormalities. Some patients may have recurrent lung infections.
Features include always present findings: Recurrent skin infections and Eczematoid dermatitis; and very common findings: Increased circulating IgE concentration. 30 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 6 | Alopecia, Dry skin, Atopic dermatitis |
ZNF341 function has not been fully characterized.
Hyper-IgE recurrent infection syndrome 3, autosomal recessive is caused by mutations in the ZNF341 gene on chromosome 20.
Genetic testing for ZNF341 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for hyper-IgE recurrent infection syndrome 3, autosomal recessive has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 1 very common feature, 4 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hyper-IgE recurrent infection syndrome 3, autosomal recessive.
10 publications have been identified in PubMed for hyper-IgE recurrent infection syndrome 3, autosomal recessive. Research spans Review / Meta-Analysis (80%), Diagnostic / Biomarker (10%), and Case Report / Case Series (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 8 | 80% |
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 5:51 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
3 |
Recurrent infections, Recurrent skin infections, Recurrent respiratory infections |
Lungs and breathing | 3 | Recurrent pneumonia, Bronchiectasis, Recurrent respiratory infections |
Bones and joints | 2 | Bone infection (osteomyelitis), Joint hypermobility |
Brain and nerves | 1 | Mild intellectual disability |
Lab test results | 1 | Increased circulating IgE concentration |
Head and neck | 1 | High palate |
Ears | 1 | Recurrent otitis media |
Heart and blood vessels | 1 | Atrial septal defect |
Testing and diagnosis research |
1 |
10% |
Patient case studies | 1 | 10% |
Justiz Vaillant AA (2026). [PMID: 29763203](https://pubmed.ncbi.nlm.nih.gov/29763203/). *Unknown Journal*. [Review / Meta-Analysis]
Hafsi W (2026). [PMID: 30247822](https://pubmed.ncbi.nlm.nih.gov/30247822/). *Unknown Journal*. [Review / Meta-Analysis]
AlYafie R (2025). [PMID: 40040707](https://pubmed.ncbi.nlm.nih.gov/40040707/). *Front Immunol*. [Review / Meta-Analysis]
Salehi M (2025). [PMID: 40114756](https://pubmed.ncbi.nlm.nih.gov/40114756/). *Health Sci Rep*. [Review / Meta-Analysis]
Thakur V (2025). [PMID: 40666020](https://pubmed.ncbi.nlm.nih.gov/40666020/). *Front Allergy*. [Review / Meta-Analysis]
Mahjoubi M (2025). [PMID: 40317072](https://pubmed.ncbi.nlm.nih.gov/40317072/). *Allergy Asthma Clin Immunol*. [Review / Meta-Analysis]
Dick JK (2025). [PMID: 39420803](https://pubmed.ncbi.nlm.nih.gov/39420803/). *Pediatr Dermatol*. [Review / Meta-Analysis]
Narahari NK (2024). [PMID: 39465929](https://pubmed.ncbi.nlm.nih.gov/39465929/). *Lung India*. [Review / Meta-Analysis]
Guo M (2024). [PMID: 38587548](https://pubmed.ncbi.nlm.nih.gov/38587548/). *Immunogenetics*. [Case Report / Case Series]
Niehues T (2024). [PMID: 39381601](https://pubmed.ncbi.nlm.nih.gov/39381601/). *Allergol Select*. [Diagnostic / Biomarker]